fbpx

See If You Qualify For The RSV Research STudy

We are conducting a study for an investigational vaccine to see if it can protect older adults from the Respiratory Syncytial Virus (RSV). To qualify for this study you must be an adults aged 60 and older.

Qualified Participants will receive:

  •  Study-related RSV vaccine at no cost
  •  Study-related medical exams at no cost
  •  Compensation up to $1,800 for time and travel
3 EASY STEPS

How It Works

Step 1

Step 1

Fill out the form to instantly see if you qualify. You can also give us a call at 561-689-0606.
Step 2

Step 2

A member of our team will reach out shortly and may ask some additional questions. 
Step 3

Step 3

If you’re qualified, you will have the opportunity to schedule an office visit for an exam. 
MEMORY LOSS STUDY

MEMORY LOSS STUDY

This Alzheimer’s Clinical Trial is enrolling men and women between the ages of 55 and 80 who have signs of early-stage Alzheimer’s disease.

RSV-PPD

RSV-PPD

This research study is to evaluate the effectiveness and safety of an oral investigational medication for the treatment of Acute Upper Respiratory Infection.

MIGRAINE SATSUMA

MIGRAINE SATSUMA

This study is to demonstrate the efficacy, safety, and tolerability of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of Migraines.

Subscribe To Our Newsletter

Subscribe to learn more about our clinical research trials, current and upcoming studies. 

Scroll to Top